Abstract
Botulinum toxin A is commonly used to reduce spasticity and dystonia in children with cerebral palsy. We report a pediatric patient who developed systemic botulism as a result of a severe overdose of the injected toxin (40 U/kg). This case highlights the importance of physicians having adequate knowledge of primate and human literature on the lethal dose, 50% of botulinum toxin A before injecting children.
Original language | English |
---|---|
Pages (from-to) | 310-313 |
Number of pages | 4 |
Journal | Clinical Neuropharmacology |
Volume | 30 |
Issue number | 5 |
DOIs | |
State | Published - Sep 2007 |
Keywords
- Botulinum toxin A
- Botulism
- Cerebral palsy